Noesis Capital Mangement Corp bought a new position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,157 shares of the company’s stock, valued at approximately $200,000.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Acorn Creek Capital LLC boosted its position in shares of Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after acquiring an additional 59 shares in the last quarter. Patrick M Sweeney & Associates Inc. boosted its position in shares of Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after purchasing an additional 59 shares in the last quarter. Hudson Value Partners LLC grew its stake in shares of Procter & Gamble by 4.1% in the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after buying an additional 60 shares during the period. Traveka Wealth LLC increased its position in Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after buying an additional 60 shares in the last quarter. Finally, Fiduciary Alliance LLC raised its stake in Procter & Gamble by 2.8% during the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock worth $371,000 after buying an additional 61 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Trading Up 0.0 %
NYSE PG opened at $179.34 on Thursday. The stock has a market capitalization of $422.35 billion, a price-to-earnings ratio of 30.92, a PEG ratio of 3.82 and a beta of 0.42. The business’s fifty day moving average is $170.22 and its 200-day moving average is $168.90. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $180.43.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.24%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.
Insider Buying and Selling at Procter & Gamble
In related news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the transaction, the insider now directly owns 11,566 shares in the company, valued at approximately $1,954,538.34. The trade was a 52.53 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the sale, the insider now directly owns 19,341 shares in the company, valued at $3,319,882.65. The trade was a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 35,233 shares of company stock worth $6,024,234 over the last ninety days. 0.18% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on PG shares. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research report on Monday, September 30th. Morgan Stanley upped their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Finally, Wells Fargo & Company boosted their target price on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 22nd. Eight analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $180.45.
View Our Latest Stock Analysis on PG
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Golden Cross Stocks: Pattern, Examples and Charts
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- ESG Stocks, What Investors Should Know
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- The 3 Best Fintech Stocks to Buy Now
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.